Prevalence of cardiovascular medication on secondary prevention after myocardial infarction in China between 1995-2015: A systematic review and meta-analysis

• Min Zhao ,

  * E-mail: m.zhao@umcutrecht.nl

  Affiliation Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlands

  http://orcid.org/0000-0002-7442-1655

  ⨯
• Kerstin Klipstein-Grobusch,

  Affiliations Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlands, Division of Epidemiology & Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa

  ⨯
• Xin Wang,

  Affiliation Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlands

  ⨯
• Johannes B. Reitsma,

  Affiliation Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlands

  ⨯
• Dong Zhao,

  Affiliation Capital Medical University Beijing Anzhen Hospital, Beijing, Beijing, China

  ⨯
• Diederick E. Grobbee,

  Affiliations Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlands, Global Geo and Health Data Centre, Utrecht University, Utrecht, Utrecht, The Netherlands

  ⨯
• Ian Graham,

  Affiliation Trinity College Dublin, Dublin, Dublin, Ireland

  ⨯
• Ilonca Vaartjes

  Affiliations Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlands, Global Geo and Health Data Centre, Utrecht University, Utrecht, Utrecht, The Netherlands

  ⨯